Biotechnology Stocks I Performance Guide: Ultragenyx Pharmaceutical Inc. (RARE)
RARE has no dividends
Table and Chart of RARE Performance
See what a $1,000 investment in RARE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RARE Returns | |
|---|---|
| Start Date | Feb-28-2014 |
| Start Price | $55.76 |
| End Date | Dec-01-2023 |
| End Price | $40.16 |
| # Prices | 119 |
| Min Date | Oct-31-2023 |
| Min Price | $35.40 |
| Max Date | Feb-26-2021 |
| Max Price | $141.54 |
| Total Return | -27.98% |
| Annualized Return | -3.26% |
| Current Value of $1,000 Purchase | $720 |
| Number Returns | 7,021 |
| Average Return | 7.56% |
| Number Profitable Returns | 3,203 |
| Percent Profitable Returns | 45.62% |
| Number Unprofitable Returns | 3,818 |
| Percent Unprofitable Returns | 54.38% |
| Profitable to Unprofitable Returns Ratio | 0.84 |
| RARE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,297,714,000 | Price to Sales | 8.04 |
| Earnings per Share | $-8.9700 |
| PE Ratio | None |
| PE to Growth Ratio | -0.24 |
| Price to Book | 103.88 |
| PRICE DATA | |
| 52 Week High | $54.98 |
| 52 Week Low | $31.52 |
| Analyst Target Price | $90.11 |
| 50-Day Moving Average | $36.17 |
| 200-Day Moving Average | $41.25 |
| FINANCIAL DATA | |
| Revenue per Share | $5.8 |
| Revenue | $410,205,000 |
| Profit Margin | -154.9% |
| Return on Equity | -2.538% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RARE Compare Returns with S&P 500
RARE Trendline Chart